Percutaneous transcatheter closure of atrial septal defect guided by transthoracic echocardiography in outpatients
- VernacularTitle:超声引导经皮房间隔缺损封堵术治疗门诊患者的可行性研究
- Author:
DENG Rundi
1
;
ZHANG Fengwen
1
;
XIE Yongquan
1
;
OUYANG Wenbin
1
;
LIU Yao
1
;
ZOU Mengxuan
1
;
WEN Bin
1
;
ZHANG Gejun
1
;
YAN Chaowu
1
;
PAN Xiangbin
1
Author Information
1. National Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences, Beijing, 100037, P.R.China
- Publication Type:Journal Article
- Keywords:
Atrial septal defect;
echocardiography;
transthoracic approach;
outpatients
- From:
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
2020;27(01):10-13
- CountryChina
- Language:Chinese
-
Abstract:
Objective To assess the feasibility and safety of percutaneous transcatheter closure of atrial septal defect (ASD) guided by transthoracic echocardiography (TTE) in outpatients. Methods From December 2016 to June 2018, 50 simple ASD patients underwent TTE-guided transcatheter closure in the outpatient operating room of our hospital (a TTE group) including 22 males and 28 females at the age of 16-48 (27.40±6.95) years. Fifty patients with simple ASD treated with the guidance of conventional fluoroscopy during the same period were treated as a control group, including 22 males and 28 females at the age of 15-48 (28.58±6.96) years. Both groups were re-examined by TTE during follow-up at 1 month, 3 months, 6 months and 1 year. Results The mean age, body weight, the size of ASD and occluder and success rate had no statistical difference between the two groups (P>0.05). Compared with the control group, the TTE group had significantly lower mean operation time (P<0.01) and less cost (P<0.01) since patients need not to be hospitalized. No related complications were found in the TTE group during follow-up. Conclusion Percutaneous transcatheter closure of ASD guided by TTE appears safe and effective for outpatients, and can significantly reduce the cost.
